Thoracic Cancer

Papers
(The H4-Index of Thoracic Cancer is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Issue Information173
Issue Information55
Issue Information45
Issue Information41
Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 140
Comparison of Early Functional Recovery Following Triportal Robot‐Assisted and Uniportal Video‐Assisted Segmentectomy in Patients With Early‐Stage Non‐Small Cell Lung Cancer: A Propensity Score‐Matche35
Sodium‐Glucose Cotransporter 2 Inhibitors for Mesenchymal–Epithelial Transition Inhibitor‐Induced Edema34
Issue Information34
Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report33
Multi‐center experience in an optimized right upper lobectomy surgical procedure in China29
Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma29
A case of eosinophilic bronchiolitis after the initiation of immune checkpoint inhibitor29
Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation 28
Electromagnetic navigational bronchoscopy‐guided dye marking to identify the subsegmental bronchus in thoracoscopic anatomic subsegmentectomy27
Pathological characteristics of lung tumors in Sri Lanka 2017–202126
Enhancing precision in lung tumor ablation through innovations in CT‐guided technique and angle control26
Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows26
PRPS2‐mediated modulation of the antitumor immune response in lung cancer through CCL2‐mediated tumor‐associated macrophages and myeloid‐derived suppressor cells25
Thoracic skeletal muscle mass predicts mortality in patients with surgery for pleural empyema: A case control study25
Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report24
PET–CT for visualizing the pathophysiology of COPD in patients with early‐stage NSCLC23
Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report23
Response to ALK‐TKIs in a lung adenocarcinoma patient harboring dual DCTN1‐ALK and ALK‐CLIP4 rearrangements23
Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non–small‐cell lung cancer patient receiving combination of PD‐1 and CTLA‐4 inhibitors: A case report23
0.0883629322052